L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
Open Access
- 4 February 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in The EMBO Journal
- Vol. 30 (5), 800-813
- https://doi.org/10.1038/emboj.2011.10
Abstract
Glioblastomas (GBMs) are highly lethal brain tumours with current therapies limited to palliation due to therapeutic resistance. We previously demonstrated that GBM stem cells (GSCs) display a preferential activation of DNA damage checkpoint and are relatively resistant to radiation. However, the molecular mechanisms underlying the preferential checkpoint response in GSCs remain undefined. Here, we show that L1CAM (CD171) regulates DNA damage checkpoint responses and radiosensitivity of GSCs through nuclear translocation of L1CAM intracellular domain (L1‐ICD). Targeting L1CAM by RNA interference attenuated DNA damage checkpoint activation and repair, and sensitized GSCs to radiation. L1CAM regulates expression of NBS1, a critical component of the MRE11–RAD50–NBS1 (MRN) complex that activates ataxia telangiectasia mutated (ATM) kinase and early checkpoint response. Ectopic expression of NBS1 in GSCs rescued the decreased checkpoint activation and radioresistance caused by L1CAM knockdown, demonstrating that L1CAM signals through NBS1 to regulate DNA damage checkpoint responses. Mechanistically, nuclear translocation of L1‐ICD mediates NBS1 upregulation via c‐Myc. These data demonstrate that L1CAM augments DNA damage checkpoint activation and radioresistance of GSCs through L1‐ICD‐mediated NBS1 upregulation and the enhanced MRN–ATM–Chk2 signalling.Keywords
This publication has 73 references indexed in Scilit:
- Potential therapeutic implications of cancer stem cells in glioblastomaBiochemical Pharmacology, 2010
- Nbs1 Flexibly Tethers Ctp1 and Mre11-Rad50 to Coordinate DNA Double-Strand Break Processing and RepairCell, 2009
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem CellsCancer Cell, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2Current Opinion in Cell Biology, 2009
- Roles for NBS1 in Alternative Nonhomologous End-Joining of V(D)J Recombination IntermediatesMolecular Cell, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- DNA damage checkpoints: from initiation to recovery or adaptationCurrent Opinion in Cell Biology, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaksNature, 2003